Anchor

Feature highlights

• Quant/Qual capability for DNA targets: CMV, EBV, HSV-1/2, VZV, HHV-6/7/8, BK/JC (coming soon).
  
  

• Differentiation built in for many kits (HSV-1 vs 2; Influenza A vs B; Norovirus GI vs GII; Monkeypox vs other Orthopox; BK vs JC; multi-analyte respiratory panels).
  
  

• Multiplex options for higher efficiency: HHV-6/7/8; Viral Respiratory Multiplex; Inf A/B + SARS-2.
  
  

• Regulatory coverage: broad CE-IVD offering for routine diagnostics plus RUO panels for research and surveillance.
  
  

• Scalable throughput: standard 100-reaction kits and 384-reaction formats for high-volume labs.
  
  

Ecosystem: ANCHOR NA Purification System (new/coming soon) for automated, high-speed nucleic acid extraction upstream of PCR.

Please Log In to access Product Datasheet ...

Main featured kits

1. Herpesvirus DNA (CE-IVD single-plex): CMV, EBV, HSV-1/2 (diff.), VZV — quant/qual detection suitable for monitoring and diagnostics.
   
   

2. Herpesvirus DNA (RUO multiplex): HHV-6/7/8 — quant/qual with three-target differentiation for research workflows.
   
   

3. Respiratory RNA (qualitative):
   
   

• CE-IVD: Influenza A/B single panel; SARS-CoV-2 v2.0 (384) for high-throughput testing.
  
  

• RUO: Viral Respiratory Multiplex (Flu A, Flu B, RSV, SARS-CoV-2) and Inf A/B + SARS-2 (384) for broader research screening.
  
  

4. Gastrointestinal & bacterial: Norovirus (GI vs GII, CE-IVD, qualitative RNA) and C. difficile toxins A/B (CE-IVD, qualitative DNA).
   
   

5. Emerging/other DNA viruses (RUO): Monkeypox/Orthopox differentiation; BK/JC (coming soon) for polyomavirus research.